cdiff

Pour la sixième édition des Rencontres pour l’égalité organisées par le Conseil départemental de Haute-Garonne, de nombreuses associations étaient présentes sur le village associatif installé le 9 mars au square Charles de Gaulle (Toulouse). Revolu’Prod, Radio Localitiz, Radio Mon Pais et Radio Occitania ont accueilli et donné la parole à ces structures dans le cadre d’un plateau radio capturé en direct.

Deuxième plateau : LGBTQIphobies & Sexisme

Pride engagée dans la lutte pour l'égalité des droits des personnes LGBTQIA+. Elle organise la Marche des Fiertés de Toulouse et mène des actions de sensibilisation et d'éducation tout au long de l'année.

Le Refuge qui vient en aide aux jeunes personnes LGBTQIA+ victimes de rejet familial ou d'homophobie/transphobie.

Contact qui accompagne les familles et les proches de personnes LGBTQIA+

Femmes, Vie, Liberté association qui s'engage pour la liberté et les droits des femmes en Iran et ailleurs par le biais d'actions auprès du public, l'organisation d'événements culturels, d'expositions et de manifestations. 
https://www.haute-garonne.fr/actualite/hengameh-yahyazadeh

Parle avec elles a pour but de favoriser la valorisation des compétences et l’émergence de la force de propositions des femmes des quartiers populaires dans l’espace public, civique, politique, social, culturel et économique.

CIDFF31 centre d’information sur les droits des femmes et des familles.

Our special guest, Julie Ann Davey, RN, MSN, ANP-C, ACNP-C, will discuss why frequent antacid use for heartburn is ruining your health.

Welcome to Humanized! Each week, we feature top experts in personalized health and functional medicine through engaging interviews and presentations. You’ll get practical advice on diet and nutrition, lifestyle, toxins and disease, hormone imbalances, nutrient deficiencies, inflammation, digestive health, mental health, the fast-changing world of genomics, and so much more.

All presentations are available as videos, podcasts or transcripts – whichever form is most convenient and enjoyable for you!

Visit us at: https://humanizedhealth.com

Subscribe to get weekly updates at: https://omniform1.com/signup/v1/5e736dfb8a48f751fdd6aa8a_604bd3c799f0b7086d1de9a4.html

Jeannie Deangelis, (@lowoxgrandma), shares her story online about her experience healing from the ravages of oxalate toxicity. Jeannie spent years suffering from diverticular infections, C-Diff, several surgeries, UTIs, migraines, and more before finding a way to improve it all by consuming low oxalate foods.

 

https://www.instagram.com/lowoxgrandma/

 

This episode is brought to you by Optimal Carnivore. Do you struggle to eat organ meat?

Optimal Carnivore was created by Carnivores for Carnivores.

They created a unique organ complex from grass-fed animals in New Zealand. It includes 9 different organs -  Liver, Brain, Heart, Thymus, Kidney, Spleen, Pancreas, Lung etc. 

Taking 6 capsules is the same as eating an ounce of raw organ meat from the butcher.

Get 10% off your order by going to https://amzn.to/3hSXXtu and using the code: carnivore10 at checkout!

(currently only shipping within the US)

 

LMNT is offering a free sample pack along with any regular purchase when you use my custom link drinklmnt.com/carnivorecast . The LMNT Sample Pack includes 1 packet of every flavor. This is the perfect offer for 1) anyone who is interested in trying all of our flavors or 2) wants to introduce a friend to LMNT. Go to drinklmnt.com/carnivorecast to claim this awesome deal!

 

What questions would you like answered or who would you like to hear from in the carnivore or research community?

In this study Dr. Sood and colleagues explore if the risk of a patient getting Clostridioides difficile Infection (CDI) is higher if the room was previously occupied by a C. diff patient. Previous single-center studies suggest that exposure to a room previously occupied by a patient with C. diff infection (CDI) may increase the risk of C. diff infection in subsequent patients. Dr. Sood and colleagues evaluated the risk of previous room occupant on CDI risk across 5 adult hospitals.

With special guest:

Geetika Sood, MD ScM Johns Hopkins University School of Medicine, Hospital Epidemiologist and Assistant Professor- John Hopkins Baltimore Medical Center and Health Service Researcher – JHHS

This week we had the honor to speak with Christian John Lillis. Christian is executive director of the Peggy Lillis Foundation for C. diff Education & Advocacy (PLF), co-founded with his brother, Liam, following the death of their mother from a Clostridioides difficile (C. diff) infection in April 2010. PLF envisions a world where C. diff is rare, treatable, and survivable. In pursuit of its vision, PLF is building a nationwide C. diff awareness movement to educate the public, empower advocates, and shape policy.

C. difficile or C-Diff is short for the name of the germ that causes the infection: Clostridioides difficile.  C. difficile can affect anyone. The risks are greater for people who:

• Are taking, or have recently taken, antibiotics

• Have spent some time in a hospital or in a long-term care facility, such as a nursing home

• Have a weakened immune system

• Are 65 years of age or older

​When C. difficile germs take hold and multiply in the gut (intestines),

they can wreak havoc.  This center of gut health is called the microbiome. When it gets out of balance your health is at risk, and infections like C. difficile can result. The most common symptoms—watery diarrhea, nausea, stomach pain or cramps—can last for days.  If not treated right away, C. difficile can lead to serious medical problems for the person who has it. A severe C. difficile infection can be fatal for certain people.

Many people may not realize that getting a relapse of the infection is highly possible. This is called recurrent C. difficile.  Did you know? C. difficile is very contagious and can become a serious health threat to others in the home and the community.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections. Courtney Jones ” Microbiome, Microbiota, and Gut Health.” Denise Cardo, MD “Everyone Has a Role in Antibiotic Awareness.” Larry Kociolek, MD “C. diff. Infections in Pediatrics.” This event was sponsored by Seres Therapeutics. Seres Therapeutics mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the program!

Welcome to the second episode of a special four (4) part series: A Symposium Created For Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Welcome to a Symposium specifically developed for patients, families, and caregivers. The Patient & Family C. diff. Symposium: where a gathering of healthcare professionals, keynote speakers, health advocates, practitioners, educators, are transforming the patient experience, and changing the way people experience C. diff. infections worldwide. Simon Cutting, Ph. D. “Bacillus, and C. diff. Spore Overview. “ Teena Chopra, MD ” Introduction to Infection Prevention.” Doe Kley, RN, MPH “C. diff. Transitioning from Hospital to Home. This event was sponsored by Seres Therapeutics, Seres Therapeutic's mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the presentations by the topic leaders joining us!

The Patient & Family C. diff. Symposium: A gathering of healthcare professionals, keynote speakers, health advocates, practitioners, educators, thought leaders, and patients who are transforming the patient experience, and changing the way people experience C. diff. infections worldwide. Program Presenter: Paul Feuerstadt, MD, FACG Barbara McGovern, MD “Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.” Paul Feuerstadt, MD ” C. diff. Overview – What is a C. diff. Infection?” Sahil Khanna, MBBS, “C. diff. Treatments and FMT Overview. “

Dr. Betsy McCaughey chairs the Committee to Reduce Infection Deaths - and she joined the program to share their work and ways for patients (and their caregivers) to reduce their risk of contracting infections while in the hospital, assisted care, rehab, or other institutional care facilities. 

With Gracie's medical history spanning nearly 40 years and containing more than 80 operations, we've lost track of how many days she (and I) spent in hospitals. But we can count the infections Gracie contracted while inpatient. MRSA, Staph, and so many others added more significant challenges to her already difficult journey - which is why I appreciated Dr. McCaughey coming on the program. 

Visit their website and see more at https://hospitalinfection.org/, and you can also download their free brochure, 15 Steps You Can Take To Reduce Your Risk of Getting a Hospital Infection.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 2 “The Burden of Clostridioides difficile Infection In the COVID-19 Era” Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy ** Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics ** Evidence-Based Hand Hygiene In the Post-COVID World.” Tamas Haidegger (Speaker) Associate Professor, Óbuda University ** We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 1 Paul Feuerstadt, MD, FACG, AGAF introduce the C Diff Foundation and provide an overview of a C. difficile infection. Simon M. Cutting, Ph.D. will present: What Makes Us Susceptible to a C. difficile Infection? We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

Our guests from Seres Therapeutics shared the latest news on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study results were equally compelling when characterized by the alternative metric of sustained clinical response, where 88.9% of patients in the SER-109 arm achieved this objective. The study’s efficacy results exceeded the statistical threshold previously provided in consultation with the U.S. Food and Drug Administration (FDA) that could allow this single clinical study to fulfill efficacy requirements for a Biologics License Application (BLA). The SER-109 safety results were favorable, with an adverse event profile comparable to a placebo. Listen in and learn more from the leading topic experts.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 2 “The Burden of Clostridioides difficile Infection In the COVID-19 Era” Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy ** Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics ** Evidence-Based Hand Hygiene In the Post-COVID World.” Tamas Haidegger (Speaker) Associate Professor, Óbuda University ** We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 1 Paul Feuerstadt, MD, FACG, AGAF introduce the C Diff Foundation and provide an overview of a C. difficile infection. Simon M. Cutting, Ph.D. will present: What Makes Us Susceptible to a C. difficile Infection? We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

Our guests from Seres Therapeutics shared the latest news on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study results were equally compelling when characterized by the alternative metric of sustained clinical response, where 88.9% of patients in the SER-109 arm achieved this objective. The study’s efficacy results exceeded the statistical threshold previously provided in consultation with the U.S. Food and Drug Administration (FDA) that could allow this single clinical study to fulfill efficacy requirements for a Biologics License Application (BLA). The SER-109 safety results were favorable, with an adverse event profile comparable to a placebo. Listen in and learn more from the leading topic experts.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections. Courtney Jones ” Microbiome, Microbiota, and Gut Health.” Denise Cardo, MD “Everyone Has a Role in Antibiotic Awareness.” Larry Kociolek, MD “C. diff. Infections in Pediatrics.” This event was sponsored by Seres Therapeutics. Seres Therapeutics mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the program!

Welcome to the second episode of a special four (4) part series: A Symposium Created For Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Welcome to a Symposium specifically developed for patients, families, and caregivers. The Patient & Family C. diff. Symposium: where a gathering of healthcare professionals, keynote speakers, health advocates, practitioners, educators, are transforming the patient experience, and changing the way people experience C. diff. infections worldwide. Simon Cutting, Ph. D. “Bacillus, and C. diff. Spore Overview. “ Teena Chopra, MD ” Introduction to Infection Prevention.” Doe Kley, RN, MPH “C. diff. Transitioning from Hospital to Home. This event was sponsored by Seres Therapeutics, Seres Therapeutic's mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the presentations by the topic leaders joining us!